TN2009000195A1 - Prime boost canine leishmania vaccine - Google Patents

Prime boost canine leishmania vaccine

Info

Publication number: TN2009000195A1
Authority: TN; Tunisia
Prior art keywords: prime boost; leishmania vaccine; canine; canine leishmania; vaccine
Prior art date: 2006-11-21

Application number

TNP2009000195A

Other languages

English (en)

Inventor

Laurent Bernard Fischer

Original Assignee

Merial Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-11-21

Filing date

2009-05-20

Publication date

2010-10-18

2009-05-20 Application filed by Merial Ltd filed Critical Merial Ltd

2010-10-18 Publication of TN2009000195A1 publication Critical patent/TN2009000195A1/fr

Links

241000222722 Leishmania <genus> Species 0.000 title abstract 4
241000282465 Canis Species 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1
238000000034 method Methods 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
239000013598 vector Substances 0.000 abstract 2
101100020251 Trypanosoma cruzi KMP-11 gene Proteins 0.000 abstract 1
230000028993 immune response Effects 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
238000002255 vaccination Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/008—Leishmania antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

TNP2009000195A 2006-11-21 2009-05-20 Prime boost canine leishmania vaccine TN2009000195A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US86684806P	2006-11-21	2006-11-21
PCT/US2007/085142 WO2008064181A2 (fr)	2006-11-21	2007-11-19	Vaccin contre la leishmania canine

Publications (1)

Publication Number	Publication Date
TN2009000195A1 true TN2009000195A1 (en)	2010-10-18

Family

ID=39430543

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TNP2009000195A TN2009000195A1 (en)	2006-11-21	2009-05-20	Prime boost canine leishmania vaccine

Country Status (11)

Country	Link
US (2)	US7794736B2 (fr)
EP (1)	EP2086580A2 (fr)
AR (1)	AR063882A1 (fr)
BR (1)	BRPI0719078A2 (fr)
CA (1)	CA2670097C (fr)
IL (1)	IL198897A (fr)
MA (1)	MA31014B1 (fr)
MX (1)	MX2009005381A (fr)
TN (1)	TN2009000195A1 (fr)
TW (1)	TWI478723B (fr)
WO (1)	WO2008064181A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2283035B1 (fr) *	2008-05-08	2015-07-29	Merial Limited	Vaccin contre la leishmaniose utilisant un immunogène salivaire de phlébotome
US8410258B2 (en)	2008-05-21	2013-04-02	Infections Disease Research Institute	Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
WO2009143006A1 (fr) *	2008-05-21	2009-11-26	Infectious Disease Research Institute	Vaccins polyprotéiques recombinants destinés au traitement et au diagnostic de la leishmaniose
GB0906906D0 (en) *	2009-04-23	2009-06-03	Univ York	Nucleic acid molecule
CA2864119C (fr)	2012-02-14	2022-05-24	Merial Limited	Vecteurs poxviraux recombinants exprimant a la fois les proteines de la rage et ox40, et vaccins fabriques a partir de ceux-ci
NZ731659A (en)	2014-11-03	2018-10-26	Merial Inc	Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
US10898460B1 (en)	2018-07-20	2021-01-26	University Of South Florida	Leishmania inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1615663T3 (da)	2003-10-24	2008-03-31	Mologen Ag	Middel til behandling af Leishmania-infektioner
BRPI0607798A2 (pt) *	2005-02-18	2010-06-22	Astrazeneca Ab	método para prognosticar uma responsividade do paciente a um inibidor de chk1, uso de um inibidor de chk1, e, kit para prognosticar uma resposta do paciente a um inibidor de chk1
EP3147296A1 (fr) *	2005-11-14	2017-03-29	Merial, Inc.	Thérapie génique pour traiter l'insuffisance rénale
US8524677B2 (en) *	2006-03-13	2013-09-03	Council Of Scientific And Industrial Research	DNA vaccine as immunoprophylaxis against Kala-azar

2007
- 2007-11-19 MX MX2009005381A patent/MX2009005381A/es active IP Right Grant
- 2007-11-19 CA CA2670097A patent/CA2670097C/fr active Active
- 2007-11-19 EP EP07868791A patent/EP2086580A2/fr not_active Ceased
- 2007-11-19 US US11/942,457 patent/US7794736B2/en active Active
- 2007-11-19 BR BRPI0719078-6A patent/BRPI0719078A2/pt not_active Application Discontinuation
- 2007-11-19 WO PCT/US2007/085142 patent/WO2008064181A2/fr active Application Filing
- 2007-11-21 TW TW096144176A patent/TWI478723B/zh active
- 2007-11-21 AR ARP070105166A patent/AR063882A1/es not_active Application Discontinuation
2009
- 2009-05-20 TN TNP2009000195A patent/TN2009000195A1/fr unknown
- 2009-05-21 IL IL198897A patent/IL198897A/en active IP Right Grant
- 2009-06-19 MA MA32020A patent/MA31014B1/fr unknown
2010
- 2010-07-20 US US12/839,580 patent/US8871225B2/en active Active

Also Published As

Publication number	Publication date
IL198897A (en)	2013-08-29
US20100285066A1 (en)	2010-11-11
WO2008064181A2 (fr)	2008-05-29
US20080241193A1 (en)	2008-10-02
TWI478723B (zh)	2015-04-01
WO2008064181A3 (fr)	2008-11-20
BRPI0719078A2 (pt)	2013-12-03
TW200826958A (en)	2008-07-01
AR063882A1 (es)	2009-02-25
US8871225B2 (en)	2014-10-28
CA2670097A1 (fr)	2008-05-29
EP2086580A2 (fr)	2009-08-12
CA2670097C (fr)	2015-10-06
US7794736B2 (en)	2010-09-14
MX2009005381A (es)	2009-06-30
IL198897A0 (en)	2011-08-01
MA31014B1 (fr)	2009-12-01

Publication	Publication Date	Title
TN2009000195A1 (en)	2010-10-18	Prime boost canine leishmania vaccine
EP2468776A3 (fr)	2012-11-14	Anticorps anti-Robo4 et utilisations associées
EP3098240A3 (fr)	2017-04-05	Anticorps anti-axl et procédés d'utilisation
PH12014501836A1 (en)	2016-03-07	Novel adjuvant compositions
WO2008116078A3 (fr)	2009-06-04	Stimulation d'une réponse immunitaire par des lipides cationiques
EP4406610A3 (fr)	2024-10-30	Traitement du cancer à l'aide d'un récepteur antigénique chimérique anti-cd19
EA201100268A1 (ru)	2011-10-31	Вакцина
TW200806316A (en)	2008-02-01	Yeast-based vaccine for inducing an immune response
CU24058B1 (es)	2014-12-26	Antagonistas de pcsk9
MX2009008918A (es)	2009-09-14	Activacion de celulas que presentan antigeno humano a traves de clec-6.
MX2019003004A (es)	2019-08-05	Composiciones para inmunizacion contra staphylococcus aureus.
CY1120430T1 (el)	2019-07-10	Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων
WO2010048394A3 (fr)	2010-08-19	Vaccin contre le virus de la peste équine
WO2007024947A3 (fr)	2007-05-31	Vaccins contre la grippe canine
IN2014CN03454A (fr)	2015-07-03
PH12014501795B1 (en)	2019-06-14	Rotavirus subunit vaccines and methods of making and use thereof
WO2009137577A3 (fr)	2010-03-25	Vaccin contre la leishmaniose utilisant un immunogène salivaire de phlébotome
UA99719C2 (ru)	2012-09-25	Вакцина для собак против болезни лайма
IN2014CN00547A (fr)	2015-04-03
MX2013013812A (es)	2014-05-28	Vacunas geneticas contra el virus hendra y el virus nipah.
GB0703976D0 (en)	2007-04-11	Liposome preparation
MX2010008170A (es)	2010-10-25	Vacunas para influenza canina.
NZ629420A (en)	2016-12-23	Sheep nematode vaccine
WO2009023164A3 (fr)	2009-04-09	Induction de l'immunité des muqueuses
TN2010000500A1 (en)	2012-05-24	Leishmania vaccine using sand fly salivary immunogen